Related Experiment Videos
A novel lentivirus vector derived from apathogenic simian immunodeficiency virus
J Stitz1, M D Mühlebach, U Blömer
1Department of Medical Biotechnology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany.
Virology
|March 7, 2002
Summary
A novel simian immunodeficiency virus (SIV) vector efficiently transfers genes into various cells, including brain cells and human CD4+ cells. This SIV-derived vector offers a promising alternative for somatic gene therapy applications.
Area of Science:
- Virology
- Gene Therapy
- Neuroscience
Background:
- Lentiviral vectors, often derived from human immunodeficiency virus type 1 (HIV-1), are crucial for gene transfer.
- Improving gene transfer efficiency in quiescent cells remains a challenge.
- Exploring alternative lentiviral vectors is essential for expanding therapeutic options.
Purpose of the Study:
- To develop and characterize a novel lentiviral vector derived from a simian immunodeficiency virus (SIV) clone.
- To assess the gene transfer capabilities of this SIV-derived vector in various cell types and in vivo.
- To evaluate its potential as an alternative to HIV-1-based vectors for somatic gene therapy.
Main Methods:
- Generation of a lentiviral vector from the SIVagm3mc clone.
- Pseudotyping the vector with vesicular stomatitis virus G-protein (VSV-G).
- Transduction of proliferating and growth-arrested mammalian cell lines, including human cells.
- In vivo inoculation into the adult rat brain striatum.
- Packaging of SIVagm transfer vector mRNA by HIV-1 vector particles.
- Generation of homologous [SIV(SIV)] vectors using SIVagm-derived envelope glycoproteins.
Main Results:
- The SIVagm-derived vector successfully transduced both proliferating and growth-arrested mammalian cell lines.
- In vivo, the vector transduced terminally differentiated neurons, oligodendrocytes, and astrocytes in the rat brain.
- SIVagm transfer vector mRNA was efficiently packaged into HIV-1 vector particles.
- Homologous SIV(SIV) vectors demonstrated selective gene transfer into human CD4+/CCR5+ cells.
Conclusions:
- The SIVagm3mc-derived lentiviral vector is effective in transducing diverse cell types, including challenging quiescent and differentiated cells.
- This vector shows potential for in vivo gene delivery in the central nervous system.
- SIVagm-derived vectors represent a valuable alternative to HIV-1-derived lentiviral vectors for somatic gene therapy.